$18.04
0.160.92%
Minimed fell 3.3% from $18.49 to $17.88, behind the S&P 500's +12.6%. Its worst day was Oct 14 (−8.6%), and its low came May 15 at $10.80.
Mar 6, 2026 – Nov 12, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
EPS of $-0.47 missed the $0.14 estimate on $790.0M revenue.
−4.4% · S&P 500 −0.2%
Minimed closed at its lowest level of the year, 41.6% below where the year started.
Story events cover the past 12 months · Times ET
−2.5% · S&P 500 −1.2%
EPS of $-0.68 missed the $-0.22 estimate on $837.0M revenue (est. $826.8M).
+15.9%, the year's best day · S&P 500 −0.7%
EPS of $0.00 missed the $0.09 estimate on $843.0M revenue (est. $828.3M).
+10.7% · S&P 500 −0.7%
Where it ended: a close of $17.88 on Nov 12, 2026. Up next: Q2 2027 earnings on Nov 24, 2026 (EPS est. $0.10, revenue est. $825.1M).
Nothing in the past 12 months.
All MMED dividend historyReplay the year: the line draws itself and stops at each of the 4 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for MMED and SPY from Benzinga historical bars. Not investment advice.